Tamoxifen Citrate
NDC 0378-0274, Tamoxifen Citrate, tablet, from Mylan Pharmaceuticals Inc..
- Product NDC
- 0378-0274
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074732
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0274 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TAMOXIFEN CITRATE20 mg/1
Pharmacologic classes
Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0378-0274-93 | 00378027493 | 30 TABLET in 1 BOTTLE (0378-0274-93) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0NADAC price for package 00378027493
GET /v1/drugs/nadac/00378027493
Use it
Look up 0378-0274 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0274 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0378-0274. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.